Status:
COMPLETED
Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation
Lead Sponsor:
Medical University of Vienna
Conditions:
Regional Blood Flow
Eligibility:
All Genders
Phase:
NA
Brief Summary
Age-related macular degeneration (AMD) is the chief cause of severe and irreversible loss of vision in developed countries. The prevalence of AMD increases dramatically with age. The early stage (or ...
Eligibility Criteria
Inclusion
- Male or female patients with unilateral choroidal neovascular AMD and 2-4 risk factors for AMD in the fellow eye.
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant Ametropy \< 4 dpt.
Exclusion
- Abuse of alcoholic beverages
- Participation in a clinical trial in the 3 weeks preceding the study
- Any signs of diabetic retinopathy
- Glaucoma
- Symptoms of a clinically relevant illness in the 3 weeks before the first study day
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00808197
Last Update
December 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Pharmacology, Medical University of Vienna
Vienna, Austria